Unbound plasma concentrations may predict neuroprotective brain concentrations: A brain microdialysis and pharmacokinetic study of enadoline in rats

Acta Neurochirurgica, Supplement

Volumn 1999, Issue SUPPL. 75, 1999, Pages 7-9

  Hinton, Joanna P ^a   Hudson, G ^a  

^a PFIZER INC   (United States)

Author keywords

Brain microdialysis; Enadoline; Neuroprotection

Indexed keywords

BENZOFURAN DERIVATIVE; ENADOLINE; NEUROPROTECTIVE AGENT; PYRROLIDINE DERIVATIVE;

ANIMAL; ARTICLE; BINDING COMPETITION; BLOOD; BRAIN; EXTRACELLULAR SPACE; METABOLISM; METHODOLOGY; MICRODIALYSIS; PLASMA; PROSPECTIVE STUDY; RADIOIMMUNOASSAY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; BENZOFURANS; BINDING, COMPETITIVE; BRAIN; EXTRACELLULAR SPACE; MICRODIALYSIS; NEUROPROTECTIVE AGENTS; PLASMA; PROSPECTIVE STUDIES; PYRROLIDINES; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0039440663     PISSN: 00651419     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6415-0_2     Document Type: Article

References (17)

1. Boxer PA, Cordon JJ, Rodolosi LC, Marcoux FW (1991) Reduction of infaret volume in a rat model of focal brain ischemia by the kappa agonist CI-977. J Cereb Blood Flow Metab 11: S429
2. DeCoster MA, Conover JR, Hunter JC, Tortella FC (1994) The neuroprotective kappa-opioid CI-977 alters glutamate-induced calcium signaling in vitro. Neuroreport 5: 2305-2310
3. Fenstermacher JD, Rapoport SI (1984) Blood-brain barrier. In: Renkin EM, Michel CC (eds) Handbook of physiology, the cerebrovascular system IV. Microcirculation, part 2. American Physiological Society, Washington, DC. pp 969-1001
4. Fettweis G, Borlak J (1996) Topics in xenobiochemistry - application of microdialysis techniques in pharmacokinetic studies. Xenobiotica 26: 473-485
5. Guttendorf RJ, Turluck DA, Wright DS et al (1989) Pharmacokinetics and bioavailabilily of the kappa analgesic PD 129290 following various routes of administration. Pharm Res 6: S-188
6. Hayward NJ, Hitchott PK, McKight AT, Woodruff GN (1993) Effect of enadoline on ischemia-induced glutamate release. Br J Pharmacol 110: 62P
7. Hayward NJ, McKnight AT, Woodruff GN (1993) Neuroprotective effect of the k-agonist enadoline (CI-977) in rat models of focal cerebral ischaemia. Europ J Neurosci 5: 961-967
8. Horwell DC (1988) Kappa opioid analgesics. Drugs Future 131: 1061-1071
9. Hunter J, Leighton K, Meecham S et al (1990) CI-977, a novel and selective agonist for the k-opioid receptor. Br J Pharmacol 101: 183-189
10. Kusumoto K, Mackay KB, McCulloch J (1992) The effect of the kappa-opioid receptor agonist CI-977 in a rat model of focal cerebral ischemia. Brain Res 576: 147-151
11. Lambert PD, Woodruff GN, Hughes J, Hunter JC (1991) Inhibition of L-glutamate: a possible mechanism of action for the neuroprotective effects of the kappa-selective agonist CI-977. Mol Neuropharmacol 1: 77
12. Mackay KB, Kusumoto K, Graham DI, McCulloch J (1993) Focal cerebral ischemia in the cat: pretreatment with a kappa-1 opioid receptor agonist: CI-977. Brain Res 618: 213-219
13. Mackay KB, Patel TR, Galbraith SL, Woodruff GN, McCulloch J (1996) The relationship between glutamate release and cerebral blood flow after focal cerebral ischaemia in the cat: effect of pretreatment with enadoline (a kappa receptor agonist). Brain Res 712: 329-334
14. Millan MH, Chapman AG, Meldrum BS (1995) Dual inhibitory-action of enadoline (CI-977) on release of amino acids in the rat hippocampus. Eur J Pharmacol 279: 75-81
15. Nordblom GD, Barksdale CM, Coon MJ et al (1990) Development of a radioimmunoassay for the novel analgesic kappa opioid receptor agonist CI-977. J Clin Immun 13: 132-139
16. Robinson TE, Justice Jr JB (eds) (1991) Microdialysis in the neurosciences. Elsevier Science Publishers BV, Amsterdam
17. Stahle L (1991) The use of microdialysis in pharmacokinetics and pharmacodynamics. In: Robinson TE, Justice JB (eds) Microdialysis in the Neurosciences. Elsevier Science Publishers BV, Amsterdam, pp 155-174